IRIS Institutional Research Information System - OPENBS Open Archive UniBS

RONCA, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.238
EU - Europa 6.266
AS - Asia 5.119
SA - Sud America 830
Continente sconosciuto - Info sul continente non disponibili 388
AF - Africa 133
OC - Oceania 40
Totale 24.014
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.960
PL - Polonia 2.560
SG - Singapore 1.682
CN - Cina 1.594
IT - Italia 862
DE - Germania 707
UA - Ucraina 662
BR - Brasile 649
HK - Hong Kong 533
VN - Vietnam 402
FI - Finlandia 336
GB - Regno Unito 259
FR - Francia 218
BD - Bangladesh 215
RU - Federazione Russa 171
CA - Canada 168
IN - India 166
TR - Turchia 166
IE - Irlanda 139
NL - Olanda 67
AR - Argentina 63
ID - Indonesia 60
SE - Svezia 56
ZA - Sudafrica 52
JP - Giappone 50
MX - Messico 49
ES - Italia 46
CZ - Repubblica Ceca 39
AU - Australia 36
BE - Belgio 34
IQ - Iraq 32
EC - Ecuador 27
CL - Cile 24
PK - Pakistan 24
AT - Austria 22
CO - Colombia 20
IR - Iran 19
TW - Taiwan 18
SA - Arabia Saudita 17
MA - Marocco 16
VE - Venezuela 16
JM - Giamaica 15
NG - Nigeria 14
PH - Filippine 14
AZ - Azerbaigian 13
CH - Svizzera 12
CR - Costa Rica 12
JO - Giordania 12
NO - Norvegia 12
KR - Corea 11
LT - Lituania 11
PE - Perù 11
PY - Paraguay 11
TH - Thailandia 11
KE - Kenya 10
MY - Malesia 10
TN - Tunisia 10
UZ - Uzbekistan 10
AE - Emirati Arabi Uniti 9
BG - Bulgaria 9
EU - Europa 9
IL - Israele 9
LK - Sri Lanka 8
EG - Egitto 7
ET - Etiopia 7
GR - Grecia 6
MU - Mauritius 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
DK - Danimarca 5
HR - Croazia 5
GE - Georgia 4
HN - Honduras 4
KZ - Kazakistan 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
AW - Aruba 3
BO - Bolivia 3
BY - Bielorussia 3
CY - Cipro 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GD - Grenada 3
HU - Ungheria 3
KH - Cambogia 3
LV - Lettonia 3
NP - Nepal 3
OM - Oman 3
RO - Romania 3
BA - Bosnia-Erzegovina 2
GT - Guatemala 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
ZM - Zambia 2
Totale 23.609
Salva come PNG Salva come JPEG
Città #
Warsaw 2.553
Ashburn 1.206
Fairfield 1.067
Singapore 970
Woodbridge 670
Hong Kong 524
San Jose 499
Jacksonville 496
Houston 493
Seattle 416
Cambridge 412
Ann Arbor 349
Chandler 347
Beijing 342
Wilmington 335
Brescia 323
The Dalles 313
New York 287
Los Angeles 283
Council Bluffs 243
Princeton 237
Helsinki 223
Dallas 158
Nanjing 152
Munich 149
Dublin 135
Lauterbourg 131
Istanbul 129
Dearborn 123
San Francisco 116
Ho Chi Minh City 115
Columbus 102
Chicago 99
Dong Ket 90
Santa Clara 90
Buffalo 84
Shanghai 83
Orem 82
Milan 81
São Paulo 70
Des Moines 67
Hanoi 66
Phoenix 61
Montreal 60
Moscow 58
Redondo Beach 54
Brooklyn 52
Denver 51
Changsha 48
Jakarta 48
Nanchang 48
San Diego 47
Atlanta 46
Shenyang 46
London 43
Toronto 41
Hebei 40
Tokyo 40
Hangzhou 38
Jinan 36
Chennai 35
Frankfurt am Main 34
Rome 34
Stockholm 33
Tianjin 33
Brussels 32
Lancaster 32
Turku 30
Amsterdam 28
Brno 27
Johannesburg 26
Boardman 23
Boston 23
Guangzhou 23
Lappeenranta 22
Nuremberg 20
Washington 20
Kunming 19
Manchester 19
Rio de Janeiro 18
Belo Horizonte 17
Melbourne 17
Mumbai 17
Ningbo 16
Taizhou 16
Haiphong 15
Mexico City 15
Verona 15
Charlotte 14
Falkenstein 14
Poplar 14
Porto Alegre 14
San Mateo 14
Abuja 13
Baku 13
Jiaxing 13
Zhengzhou 13
Amman 12
Baghdad 12
Berlin 12
Totale 16.384
Salva come PNG Salva come JPEG
Nome #
Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer 902
Tumor angiogenesis revisited: Regulators and clinical implications 448
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 406
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 365
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 345
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 321
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 310
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers 304
Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer 296
Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics. 295
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors 291
The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors. 287
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 280
Caveolin-1 overexpression in the human embryonal rhabdomyosarcoma RD cells increases tumor growth and metastasis in vivo through a phospho-ERK-dependent signaling pathway 275
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR 268
Caveolin-1 overexpression accelerates tumor growth and metastasis of embryonal rhabdomyosarcoma 266
Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents 261
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis. 259
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 256
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3',4',5'-Trimethoxyphenyl)-2-Aryl-1H-Imidazole 230
Embryonic Stem Cells as a Model System to Elucidate Early Events in Cardiac Specification and Determination 226
Stromal delivery of long Pentraxin-3 impairsFGF7FGFR-dependent tumor growth and metastasis 226
Long pentraxin-3 follows and modulates bladder cancer progression 225
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 217
Long Pentraxin 3/TSG-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis 216
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells. 208
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma. 208
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 208
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 205
Evaluating the effects of fluorine on biological properties and metabolic stability of some antitubulin 3-substituted 7-phenyl-pyrroloquinolinones 205
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 204
The Novel Antitubulin Agent TR-764 Strongly Reduces Tumor Vasculature and Inhibits HIF-1α Activation 199
Natural Histogel-Based Bio-Scaffolds for Sustaining Angiogenesis in Beige Adipose Tissue 197
Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth 195
Molecular cloning and knockdown of galactocerebrosidase in zebrafish: New insights into the pathogenesis of Krabbe's disease. 194
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. 191
Caveolin-1 enhances metastasis formation in a human model of embryonal rhabdomyosarcoma through Erk signaling cooperation 190
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma 189
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 188
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 188
Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2- d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors 187
Enhanced SPARCL1 expression in cancer stem cells improves preclinical modeling of glioblastoma by promoting both tumor infiltration and angiogenesis 187
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. 186
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation. 186
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach 186
Beta-Galactosylceramidase deficiency: neurovascular implications 183
H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis 183
Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case 179
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. 178
Synthesis, in vitro and in vivo biological evaluation of substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones as new potent anticancer agents 177
Hyper-Activation of STAT3 Sustains Progression of Non-Papillary Basal-Type Bladder Cancer via FOSL1 Regulome 174
Design, synthesis and biological evaluation of novel vicinal diaryl-substituted 1H-Pyrazole analogues of combretastatin A-4 as highly potent tubulin polymerization inhibitors 173
Dendritic cells in inflammatory angiogenesis and lymphangiogenesis 171
Circulating microRNAs and Their Role in Multiple Myeloma 171
Ten Years of CRISPRing Cancers In Vitro 170
Long pentraxin 3: A novel multifaceted player in cancer 169
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 168
Long pentraxin-3 modulates the angiogenic activity of fibroblast growth factor-2 165
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 164
Future applications of FGF/FGFR inhibitors in cancer 160
Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone-Regulated Tumors. 155
Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy 153
Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development. 152
Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-Assemblies 151
Human iPSC modeling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes 151
Vascular disrupting activity of combretastatin analogues 150
Design, Synthesis, in Vitro and in Vivo Anticancer and Antiangiogenic Activity of Novel 3-Arylamino Benzofuran Derivatives Targeting the Colchicine Site on Tubulin 149
Influenza virus entry via the GM3 ganglioside-mediated platelet-derived growth factor receptor β signalling pathway 149
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 148
Discovery of novel FGF trap small molecules endowed with anti-myeloma activity 147
The autocrine fgf/fgfr system in both skin and uveal melanoma: Fgf trapping as a possible therapeutic approach 146
Inflammatory cells and chemokines sustain FGF2-induced angiogenesis 143
Heparin derivatives as angiogenesis inhibitors 140
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer 140
Uptake Profiles of Human Serum Exosomes by Murine and Human Tumor Cells through Combined Use of Colloidal Nanoplasmonics and Flow Cytofluorimetric Analysis 138
Collagen/PCL electrospun fibers loaded with polyphenols: Curcumin and resveratrol comparison 135
Fibroblast growth factor receptor-1 expression is required for hematopoietic but not endothelial cell development. 135
Krabbe Disease and zebrafish: key-role of galactocerebrosidase in CNS development 135
FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation-Induced Mitochondrial Oxidative Stress 134
lnvolvement of N-formyl peptide receptors in modulating the pro-angiogenic pro-inflammatory activity of human vitreous in proliferative diabetic retinopathy (POR) 133
Biocompatible cellulose nanocrystal-based Trojan horse enables targeted delivery of nano-Au radiosensitizers to triple negative breast cancer cells 132
Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice 132
Benzoxaborinine, New Chemotype for Carbonic Anhydrase Inhibition: Ex Novo Synthesis, Crystallography, In Silico Studies, and Anti-Melanoma Cell Line Activity 125
Novel 2,4-Dichloro-5-sulfamoylbenzoic Acid Oxime Esters: First Studies as Potential Human Carbonic Anhydrase Inhibitors 124
An embryonic stem cell perspective for FGFR1 signaling in cardiovascular development 124
An orthotopic model of uveal melanoma in zebrafish embryo: A novel platform for drug evaluation 124
Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer 123
Halting the FGF/FGFR axis leads to anti-tumor activity in Waldenström's Macroglobulinemia by silencing MYD88 123
Stromal expression of long Pentraxin-3 impairs tumor growth and metastasis 122
Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitness 121
FGF Ligand Traps for the Therapy of FGF-Dependent Tumors 121
Targeting FGF/FGFR1 system for an integrated anti-tumor/anti-angiogenic therapy of cancer 120
HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies 119
The zebrafish knockdown of galactocerebrosidase contributes to understand the human Krabbe Disease 118
Isolation and characterization of neutralizing anti-FGFR1 single chain antibodies 114
FGFR-1 as an anti-angiogenic/anti-tumor target for squamous cell lung cancer therapy. 114
Choline kinase alpha inhibition by EB-3D triggers cellular senescence, reduces tumor growth and metastatic dissemination in breast cancer 114
Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma 114
Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer 114
Carbonic anhydrase IX: An atypical target for innovative therapies in cancer 112
Totale 19.555
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.036
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.036
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022837 0 0 47 27 19 53 73 74 45 116 100 283
2022/20231.027 175 32 57 56 99 241 6 90 145 4 64 58
2023/20241.263 76 30 136 54 48 207 52 73 260 63 56 208
2024/20252.929 34 40 43 445 240 268 250 160 373 210 488 378
2025/20266.866 607 706 415 836 750 482 1.046 312 421 623 329 339
2026/20271.375 934 349 92 0 0 0 0 0 0 0 0 0
Totale 24.014